We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CiRC

News List

CiRC Biosciences Announces Orphan Drug Designation for Retinitis Pigmentosa americanpharmaceuticalreview
March 17, 2021
CiRC Biosciences announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for chemically induced photoreceptor-like cells (CiPCs) for the treatment of retinitis pigmentosa (RP).
Paragon Biosciences Expands Cell and Gene Therapy Platform contractpharma
February 09, 2021
Paragon Biosciences, a life science innovator that creates, invests in and builds life science companies in biopharmaceuticals, cell and gene therapy and synthetic biology utilizing artificial intelligence, has launched CiRC Biosciences ...